Importance of the liposomal cationic lipid content and type in tumor vascular targeting: Physicochemical characterization and in vitro studies using human primary and transformed endothelial cells

Endothelium: Journal of Endothelial Cell Research

Volumn 15, Issue 4, 2008, Pages 189-201

  Dabbas, Sudhir ^a   Kaushik, Ritu R ^a   Dandamudi, Suman ^a   Kuesters, Geoffrey M ^a   Campbell, Robert B ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cancer Chemotherapy; Cationic Liposomes; Drug Delivery; Endothelium; Vascular Targeting

Indexed keywords

1,2 DIMYRISTOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DIOLEOYL 3 DIMETHYLAMMONIOPROPANE; 1,2 DIOLEOYL 3 PHOSPHOETHANOLAMINE; 1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DIPALMITOYL 3 DIPALMITOYLPHOSPHATIDYLETHANOLAMINE N (LISSAMINE RHODAMINE B SULFONYL); 1,2 DISTEAROYL 3 TRIMETHYLAMMONIOPROPANE; ANTINEOPLASTIC AGENT; CATION; CHOLESTEROL; DOXORUBICIN; DRUG CARRIER; ETOPOSIDE; LIPID; LIPOSOME; MACROGOL; PROTEOHEPARAN SULFATE;

ARTICLE; BINDING AFFINITY; CANCER CHEMOTHERAPY; CELL IMMORTALIZATION; CELL INTERACTION; CELL TRANSFORMATION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID ANALYSIS; LUNG BLOOD VESSEL; MICROVASCULATURE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN BLOOD VESSEL; SURFACE CHARGE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION; ZETA POTENTIAL;

CELL LINE; CELL LINE, TRANSFORMED; CELL SURVIVAL; DOXORUBICIN; ENDOTHELIUM, VASCULAR; ETOPOSIDE; HUMANS; LIPIDS; LIPOSOMES; PHOSPHATIDYLCHOLINES; PULMONARY CIRCULATION;

EID: 48549093418     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320802228583     Document Type: Article

References (48)

1. Ades, E. A., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C. and Lawley, T. J. (1992) HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. 99, pp. 683-690.
2. Baldwin, A. L., Wu, N. Z. and Stein, D. L. (1991) Endothelial surface charge of intestinal mucosal capillaries and its modulation by dextran. 42, pp. 160-178.
3. Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavassi, R. and Taraboletti, G. (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. 2, pp. 1843-1849.
4. Brower, V. (1999) Tumor angiogenesis-new drugs on the block. 17, pp. 963-968.
5. Burrows, F. J. and Thorpe, P. E. (1994) Vascular targeting - a new approach to the therapy of solid tumors. 64, pp. 155-174.
6. Campbell, R. B. (2006) Tumor physiology and delivery of nanopharmaceuticals. 6, pp. 501-510.
7. Campbell, R. B., Balasubramanian, S. V. and Straubinger, R. M. (2001) Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. 90, pp. 1091-1105.
8. Campbell, R. B., Balasubramanian, S. V. and Straubinger, R. M. (2001) Physical properties of phospholipid-cationic lipid interactions: Influences on domain structure, liposome size and cellular uptake. 15, pp. 1227-1539.
9. Campbell, R. B., Fukumura, D., Brown, E. B., Mazzola, M. L., Izumi, Y., Jain, R. K., Torchilin, V. P. and Munn, L. L. (2002) Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. 62, pp. 6831-6836.
10. Chaplin, D. J. and Dougherty, G. J. (1999) Tumour vasculature as a target for cancer therapy. 1, pp. 57-64.
11. Charonis, A. S. and Wissig, S. L. (1983) Anionic sites in basement membranes. Differences in their electrostatic properties in continuous and fenestrated capillaries. 25, pp. 265-285.
12. Dandamudi, S. and Campbell, R. B. (2007) Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. 1768, pp. 427-438.
13. Dandamudi, S. and Campbell, R. B. (2007) The drug loading, cytotoxicity and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. 28, pp. 4673-4683.
14. Dass, C. R. and Choong, P. F. (2006) Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: Lessons from gene therapy. 6, p. 17.
15. Denekamp, J. (1984) Vasculature as a target for tumor therapy. 4, pp. 28-438.
16. Denekamp, J. and Hobson, B. (1982) Endothelial-cell proliferation in experimental tumours. 46, pp. 711-720.
17. Emmenegger, U., Morton, G. C., Francia, G., Shaked, Y., Franco, M., Weinerman, A., Man, S. and Kerbel, R. S. (2006) Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: A well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia. 66, pp. 1664-1674.
18. Evans, R. R., Calmels, T. P., Pitt, B. R., Brookens, M. A., Johnson, C. S., Modzelewski, R. A. and Lazo, J. S. (1994) Gene therapy and endothelial cell targeting for cancer. 716, pp. 257-264.
19. Felgner, P., Gadek, T., Holm, M., Roman, R., Chan, H., Wenz, M., Northrop, J., Ringold, G. and Danielsen, M. (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. 84, pp. 7413-7417.
20. Folkman, J. (1992) The role of angiogenesis in tumor growth. 3, pp. 65-71.
21. Folkman, J. (1971) Tumor angiogenesis: Therapeutic implications. 285, pp. 1182-1186.
22. Gately, S. and Kerbel, R. S. (2001) Antiangiogenic scheduling of lower dose cancer chemotherapy. 7, pp. 427-436.
23. Hardebo, J. E. and Kahrstrom, J. (1985) Endothelial negative surface charge areas and blood-brain barrier function. 125, pp. 495-499.
24. Jain, R. K. (1998) The next frontier of molecular medicine: Delivery of therapeutics. 4, pp. 655-657.
25. Jain, R. K. (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. 9, pp. 253-266.
26. Kalra, A. V. and Campbell, R. B. (2006) Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting. 23, pp. 2809-2817.
27. Kato, Y., Mawatari, H., Nishimura, S., Sakura, N. and Ueda, K. (2003) Determination of etoposide serum concentration in small pediatric samples by an improved method of reversed-phase high-performance liquid chromatography. 57, pp. 21-24.
28. Kerbel, R. S. (1991) Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. 13, pp. 31-36.
29. Kunstfeld, R., Weckenhauser, G., Michaelis, U., Teifel, M., Umek, W., Naujoks, K., Wolff, K. and Petzelbauer, P. (2003) Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. 120, pp. 476-482.
30. Lee, C. M., Tanaka, T., Murai, T., Kondo, M., Kimura, J. S. W., Kitagawa, T., Ito, T., Matsuda, H. and Matsuda, M. M. (2002) Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. 62, pp. 4282-4288.
31. Levchenko, T. S., Rammohan, R., Lukyanov, A. N., Whiteman, K. R. and Torchilin, V. P. (2002) Liposome clearance in mice: The effect of a separate and combined presence of surface charge and polymer coating. 240, pp. 95-102.
32. McLean, J. W., Fox, E. A., Baluk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y. and McDonald, D. M. (1997) Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. 273, pp. 387-404.
33. Mislick, K. A. and Baldeschwieler, J. D. (1996) Evidence for the role of proteoglycans in cation-mediated gene transfer. 93, pp. 12349-12354.
34. Mounkes, L. C., Zhong Cipres, W., Palacin, G., Heath, T. D. and Debs, R. (1998) Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. 1998, pp. 26164-26170.
35. Pasquier, E., Honore, S., Pourroy, B., Jordan, M. A., Lehmann, M., Briand, C. and Braguer, D. (2005) Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. 65, pp. 2433-2440.
36. Ran, S., Downes, A. and Thorpe, P. E. (2002) Increased exposure of anionic phospholipids on the surface of tumor blood vessels. 62, pp. 6132-6140.
37. Roberts, W. G. and Palade, G. E. (1997) Neovasculature induced by vascular endothelial growth factor is fenestrated. 57, pp. 765-772.
38. Sengupta, S., Tyagi, P., Chandra, S., Kochupillai, V. and Gupta, S. K. (2001) Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor. 62, pp. 163-171.
39. Sengupta, S., Tyagi, P., Velpandian, T., Gupta, Y. K. and Gupta, S. K. (2000) Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies. 42, pp. 459-464.
40. Simionescu, M., Simionescu, N., Santoro, F. and Palade, G. E. (1985) Differentiated microdomains of the luminal plasmalemma of murine muscle capillaries: Segmental variations in young and old animals. 100, pp. 1396-1407.
41. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMohan, J., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. 82, pp. 1107-1112.
42. Strieth, S., Eichhorn, M. E., Sauer, B. and Dellian, M. (2004) Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. 110, pp. 117-124.
43. Strieth, S., Eichhorn, M. E., Sauer, B., Schulze, B., Teifel, M., Michaelis, U. and Dellian, M. (2004) Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposome impairs functional tumor microvasculature. 110, pp. 117-124.
44. Takahashi, Y., Kitadai, Y., Bucans, C. D., Clearly, K. R. and Ellis, L. M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR correlates with vascularity, metastasis, and proliferation of human colon cancer. 55, pp. 3964-3968.
45. Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D. and McDonald, D. M. (1998) Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. 101, pp. 1401-1413.
46. Vijayagopal, P., Figueoroa, J. E. and Levine, E. A. (1998) Altered composition and increased endothelial cell proliferative activity of proteoglycans isolated from breast carcinoma. 68, pp. 250-254.
47. Vincent, S., DePace, D. and Finkelstein, S. (1988) Distribution of anionic sites on the capillary endothelium in an experimental brain tumor model. 1988, pp. 45-67.
48. Zuidam, N. J. and Barenholz, Y. (1997) Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin. 1329, pp. 211-222.